Denemek ALTIN - Özgür

Luxury automakers set to make a comeback at auto expo this year

Mint New Delhi

|

January 17, 2025

After skipping the 2023 edition, luxury automakers Mercedes Benz and BMW have returned to the Auto Expo 2025, now rebranded as the Bharat Mobility Global Expo.

- Alisha Sachdev

Both brands are leveraging the platform to showcase their cutting-edge models and drum up consumer sentiment after a year of strong sales, even as the overall passenger car market slowed.

The luxury car market in India is estimated to have closed 2024 with sales of 51,000 units, representing a 6% year-on-year (y-o-y) growth.

While the overall segment grew, it was a mixed show, with some automakers driving growth while others struggled to retain volumes.

Mercedes Benz, India's largest luxury carmaker, saw a robust 12.4% growth in 2024, delivering 19,565 vehicles.

BMW, its closest rival, grew by 12.8%, selling 15,012 units.

However, Audi continued to face challenges, with a sharp 26.7% decline in sales, amounting to just 5,816 units.

Jaguar Land Rover (JLR) stood out with stellar growth rates of 35%, while Japanese luxury carmaker Lexus saw sales grow 13.8% y-o-y, according to industry estimates, although their volumes remain much smaller.

Volvo and MINI, on the other hand, reported double-digit declines of 19.6% and 18.4%.

Mint New Delhi'den DAHA FAZLA HİKAYE

Mint New Delhi

Mint New Delhi

How CCI plans to watch AI use by companies

The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.

time to read

2 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY

The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.

time to read

3 mins

October 08, 2025

Mint New Delhi

US TARIFF-LED RISKS PERSIST FOR INDIA

The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.

time to read

3 mins

October 08, 2025

Mint New Delhi

Nykaa fashion arm sashays again—spotlight on the stride

The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.

time to read

1 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

‘RBI focusing on new use cases for e-rupee’

The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.

time to read

1 mins

October 08, 2025

Mint New Delhi

Nobel physics prize goes to pioneers of quantum mechanics

US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.

time to read

1 min

October 08, 2025

Mint New Delhi

Nvidia to continue sponsoring H-1B visas

Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.

time to read

1 min

October 08, 2025

Mint New Delhi

AstraZeneca to sell cancer drug in India

AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.

time to read

1 min

October 08, 2025

Mint New Delhi

Fintech lending growth slows after clampdown

But delinquency and deep-stage stress are still elevated, shows report

time to read

2 mins

October 08, 2025

Mint New Delhi

CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY

The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.

time to read

1 mins

October 08, 2025

Listen

Translate

Share

-
+

Change font size